Literature DB >> 35784773

Hypofractionated radiation therapy of a thyroid tumor in a pet raccoon (Procyon lotor).

Cassie Kroncke1, Samuel E Hocker1, Katherine Rainwater1, David Ruslander1, Eli B Cohen1, Sara Gardhouse1.   

Abstract

Thyroid neoplasia has been documented in raccoons; however, successful management and treatment has not been well-described. A 15-year-old, intact female pet raccoon (Procyon lotor) was examined for evaluation of a right-sided ventral cervical mass and a cough of 4 to 5 mo duration. Cytology and computed tomography (CT) findings of the mass were most consistent with a thyroid tumor. The raccoon was treated with a hypofractionated external beam radiation protocol (8 Gy/fraction for 4 once/wk fractions). Treatments were well-tolerated and no radiation-induced side effects were detected. This is the first report of radiation treatment of thyroid neoplasia in a raccoon, presenting the challenges of animals that are difficult to handle or medicate. Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.

Entities:  

Mesh:

Year:  2022        PMID: 35784773      PMCID: PMC9207980     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.075


  18 in total

1.  Treatment of an amelanotic melanoma using radiation therapy in a lesser Madagascar hedgehog tenrec (Echinops telfairi).

Authors:  Tara M Harrison; Pedro Dominguez; Kim Hanzlik; James G Sikarskie; Dalen Agnew; Ingrid Bergin; Scott D Fitzgerald; Barbara E Kitchell; Elizabeth McNiel
Journal:  J Zoo Wildl Med       Date:  2010-03       Impact factor: 0.776

2.  Thyroid Cancer Brain Metastasis: Survival and Genomic Characteristics of a Large Tertiary Care Cohort.

Authors:  Joseph R Osborne; Jessica D Kondraciuk; Samuel L Rice; Xiaosun Zhou; Andrea Knezevic; Daniel E Spratt; Mona Sabra; Steven M Larson; Ravinder K Grewal
Journal:  Clin Nucl Med       Date:  2019-07       Impact factor: 7.794

Review 3.  Adenomas and carcinomas of the canine and feline thyroid.

Authors:  I Leav; A L Schiller; A Rijnberk; M A Legg; P J der Kinderen
Journal:  Am J Pathol       Date:  1976-04       Impact factor: 4.307

4.  Toceranib phosphate in the treatment of canine thyroid carcinoma: 42 cases (2009-2018).

Authors:  Sabina Sheppard-Olivares; Nora M Bello; Elizabeth Wood; Anna Szivek; Barbara Biller; Samuel Hocker; Raelene M Wouda
Journal:  Vet Comp Oncol       Date:  2020-02-13       Impact factor: 2.613

5.  Thyroid neoplasms in the dog. A clinicopathologic study of fifty-seven cases.

Authors:  R S Brodey; D F Kelly
Journal:  Cancer       Date:  1968-08       Impact factor: 6.860

6.  Hypofractionated radiation therapy for invasive thyroid carcinoma in dogs: a retrospective analysis of survival.

Authors:  M J Brearley; A M Hayes; S Murphy
Journal:  J Small Anim Pract       Date:  1999-05       Impact factor: 1.522

7.  Computed tomographic features of basihyoid ectopic thyroid carcinoma in dogs.

Authors:  F Rossi; E Caleri; B Bacci; R Drees; A Groth; G Hammond; M Vignoli; T Schwarz
Journal:  Vet Radiol Ultrasound       Date:  2013-06-23       Impact factor: 1.363

8.  Treatment of thyroid carcinoma in dogs by surgical resection alone: 20 cases (1981-1989).

Authors:  M K Klein; B E Powers; S J Withrow; C R Curtis; R C Straw; G K Ogilvie; K L Dickinson; M F Cooper; M Baier
Journal:  J Am Vet Med Assoc       Date:  1995-04-01       Impact factor: 1.936

9.  Diagnosis and treatment of a dermal malignant melanoma in an African lion (Panthera leo).

Authors:  James C Steeil; Juergen Schumacher; Katherine Baine; Edward C Ramsay; Patricia Sura; Rebecca Hodshon; Robert L Donnell; Nathan D Lee
Journal:  J Zoo Wildl Med       Date:  2013-09       Impact factor: 0.776

10.  Safety and Efficacy of Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Canine Thyroid Carcinoma.

Authors:  Ber-In Lee; Susan M LaRue; Bernard Seguin; Lynn Griffin; Amber Prebble; Tiffany Martin; Del Leary; Mary-Keara Boss
Journal:  Vet Comp Oncol       Date:  2020-06-09       Impact factor: 2.613

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.